Caprion Biosciences

Caprion Biosciences in its acquisition of Primity Bio


Caprion Biosciences




Mergers and Acquisitions

Date Closed

August 2018


Pharmaceuticals, Biotech & Life Sciences

Lead Office



On August 21, 2018, Caprion Biosciences announced that it has acquired Primity Bio Inc. 

Caprion will leverage Primity's strong technological capabilities and innovative track record to further expand its immunology and molecular profiling service offering as well as its ability to globally support its clients.

With this acquisition, Caprion adds an operational location in the US in addition to those of its headquarters in Montreal, Canada, and its European site in Gosselies, Belgium.

Primity is a specialized provider of biomarker and immune monitoring services located in Fremont, California.

Caprion is a Montreal, Quebec-based provider of specialized immunology and proteomics laboratory services to the pharmaceutical and biotechnology industry and is backed by GHO Capital Partners.

Osler, Hoskin & Harcourt LLP represented Caprion with a team consisting of Shahir Guindi, Sophie Amyot, Calvin Leung (Corporate), Alain Fournier and Ramin Wright (Tax).